
<DOC>
<DOCNO>WT02-B18-154</DOCNO>
<DOCOLDNO>IA092-000988-B014-112</DOCOLDNO>
<DOCHDR>
http://www.cytrx.com:80/privy.htm 206.216.36.35 19970110093653 text/html 3450
HTTP/1.0 200 OK
Date: Friday, 10-Jan-97 09:39:34 GMT
Server: WebSite/1.1
Allow-ranges: bytes
Accept-ranges: bytes
Content-type: text/html
Last-modified: Friday, 03-Jan-97 17:15:52 GMT
Content-length: 3235
</DOCHDR>
<HTML>

<HEAD>

<TITLE>January Press Release</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Microsoft Word 2.0z">
</HEAD>


<BODY background=/icons/wrich/bg.gif>

<table width=95%><tr>
<td align=left>	
	<img src=/icons/cytrx.48pt.gif>
	</td>
<td align=right>
	<img src=/icons/multiopp.gif>
	</td>
</tr></table>
<img src=/icons/wrich/redline.gif>

<P>

<P>
<B>VETLIFE ANNOUNCES MARKETING AND DISTRIBUTION
AGREEMENT WITH IVY LABORATORIES</B><BR>

<P>
<B>Atlanta, Georgia (January 29, 1996) -</B>
<BR>
<P>
Vetlife, Inc. today announced the signing
of an agreement with Ivy Laboratories, Inc. to market and distribute
Ivy's line of FDA approved cattle growth products and devices
in North America.  The newly created Vetlife Cattle Marketing
Group will begin marketing products by January, 1997.  Vetlife
is a wholly owned subsidiary of CytRx Corporation [NASDAQ:CYTR].

<P>
“Our agreement with Ivy is a
significant milestone for Vetlife,” commented Richard O.
 Shuler, president and CEO of Vetlife. “We are confident
it will enable Vetlife to generate sales, profits and cash flow
from Ivy's FDA approved products beginning in 1997.  We
are pleased to partner with Ivy in serving the cattle industry
and are looking forward to working closely with them to introduce
new products and devices to the beef market.”

<P>
Vetlife will become Ivy's master
distributor for the United States and Canada. Vetlife has exclusive
rights to market several new growth promotion products currently
under development by Ivy.

<P>
“This agreement paves the way
for the commercialization of Vetlife's new technologies
currently in development,” continued Shuler. “We
expect the Ivy partnership will generate income that will enable
the acceleration of our other development  programs.”

<P>
Ivy Laboratories, Inc. located in Overland
Park, Kansas, is a manufacturer of FDA approved growth products
for use in cattle.  Ivy also develops devices used to apply these
products.

<P>
Vetlife is engaged in the development,
licensing and marketing of technologies to improve the value of
food animal products to the cattle, poultry, swine and dairy industries.
 Vetlife products are targeted at  improving product benefits
or reducing cost without compromising safety or quality.  Products
under development include a non-antibiotic growth promoter for
use in poultry and swine, adjuvants to enhance animal vaccines
and antibiotic potentiators to overcome antibiotic resistance
or reduce required doses.  

<P>
CytRx Corporation and its subsidiaries
are engaged in the development of pharmaceutical products.  In
addition to Vetlife, CytRx's Vaxcel subsidiary is developing
the Optivax&#174; vaccine delivery system. Proceutics provides
high quality preclinical development services to the pharmaceutical
industry. 


<P>
<BR>

<img src="/icons/rain_line.gif">	
<p>
<b>
[ <a href="/index.html">Home</a> 
| <a href="http://www.titermax.com">TiterMax</a> 
| <a href="/financial/overview.html">Investor Info</a> 
| <a href="/communications.html">Communications</a> 
| <a href="/adproceu.html">Proceutics</a>  
] </b>
<p>

</BODY>

</HTML>


</DOC>